Aetna Inc. (NYSE:AET) announced a quarterly dividend on Friday, September 30th. Shareholders of record on Thursday, October 13th will be paid a dividend of 0.25 per share on Friday, October 28th. This represents a $1.00 annualized dividend and a yield of 0.87%.
Shares of Aetna (NYSE:AET) traded up 0.22% during mid-day trading on Friday, reaching $115.28. The company’s stock had a trading volume of 607,175 shares. Aetna has a 12 month low of $92.42 and a 12 month high of $123.57. The stock has a market capitalization of $40.44 billion, a P/E ratio of 16.89 and a beta of 0.62. The company has a 50 day moving average price of $116.97 and a 200 day moving average price of $115.70.
Aetna (NYSE:AET) last announced its quarterly earnings data on Tuesday, August 2nd. The company reported $2.21 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.12 by $0.09. Aetna had a return on equity of 16.44% and a net margin of 3.89%. The business earned $15.95 billion during the quarter, compared to analyst estimates of $15.69 billion. During the same period last year, the company earned $2.05 earnings per share. Aetna’s quarterly revenue was up 4.7% compared to the same quarter last year. On average, equities research analysts anticipate that Aetna will post $8.05 earnings per share for the current fiscal year.
In other news, insider Shawn M. Guertin sold 45,328 shares of Aetna stock in a transaction that occurred on Tuesday, August 23rd. The shares were sold at an average price of $120.21, for a total value of $5,448,878.88. Following the completion of the transaction, the insider now owns 44,883 shares in the company, valued at $5,395,385.43. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Jeffrey E. Garten sold 7,100 shares of Aetna stock in a transaction that occurred on Wednesday, September 7th. The shares were sold at an average price of $116.51, for a total transaction of $827,221.00. The disclosure for this sale can be found here. Company insiders own 0.90% of the company’s stock.
Several hedge funds and other institutional investors have recently bought and sold shares of AET. Capital International Investors boosted its position in Aetna by 7.5% in the second quarter. Capital International Investors now owns 4,650,500 shares of the company’s stock worth $567,966,000 after buying an additional 324,000 shares during the period. APG Asset Management N.V. boosted its position in Aetna by 34.6% in the second quarter. APG Asset Management N.V. now owns 641,470 shares of the company’s stock worth $78,343,000 after buying an additional 165,000 shares during the period. Mitsubishi UFJ Trust & Banking Corp boosted its position in Aetna by 10.2% in the second quarter. Mitsubishi UFJ Trust & Banking Corp now owns 949,612 shares of the company’s stock worth $115,976,000 after buying an additional 88,010 shares during the period. Laurion Capital Management LP boosted its position in Aetna by 2,084.6% in the second quarter. Laurion Capital Management LP now owns 69,906 shares of the company’s stock worth $8,538,000 after buying an additional 66,706 shares during the period. Finally, Franklin Resources Inc. boosted its position in Aetna by 6.9% in the second quarter. Franklin Resources Inc. now owns 1,016,120 shares of the company’s stock worth $124,099,000 after buying an additional 65,911 shares during the period. Institutional investors own 91.95% of the company’s stock.
AET has been the topic of several analyst reports. Wells Fargo & Co. reissued a “buy” rating on shares of Aetna in a research report on Thursday, June 2nd. Zacks Investment Research downgraded shares of Aetna from a “buy” rating to a “hold” rating in a research report on Monday, August 8th. FBR & Co reissued a “hold” rating on shares of Aetna in a research report on Wednesday, August 17th. Jefferies Group reissued a “hold” rating on shares of Aetna in a research report on Tuesday, September 6th. Finally, Credit Suisse Group AG reissued a “hold” rating and set a $120.00 target price on shares of Aetna in a research report on Tuesday, September 13th. Seven analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $132.79.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. The Health Care segment’s products and services consist of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an insured basis and an employer-funded, or administrative services contact, basis and emerging businesses products and services, such as accountable care solutions (ACS).
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.